Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bioxytran, Inc. BIXT

Set alert

Price alert · BIXT

All alert types
0.02 USD 0.00 +13.28%

At close · Oct 30

0.0206 Day range 0.0206
0.02 52-week range 0.0949
YTD
-69.39%
1 year
-66.23%
Open
0.0206
Prev close
0.02048
Mkt cap
2.66M
Vol
8.00K
Avg vol
98.42K
EPS
-0.02
P/E
0.00
More statistics
Low
0.0206
High
0.0206
Earnings
Nov 2, 2023

3M chart

Chart tools
Interval
1m5m15m30m

Signals (42)
NameDateAgo
SMA: BearishNov 2, 20268 hours ago
SMA: BearishNov 2, 20268 hours ago
SMA: BullishOct 30, 20263 days ago
SMA: BullishOct 30, 20263 days ago
SMA: BearishOct 28, 20265 days ago
SMA: BearishOct 28, 20265 days ago
SMA: BullishOct 27, 20266 days ago
SMA: BullishOct 27, 20266 days ago
SMA: BearishOct 26, 20261 week ago
SMA: BearishOct 26, 20261 week ago
MACD: Sell SignalOct 26, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishOct 19, 20262 weeks ago
SMA: BearishOct 19, 20262 weeks ago
SMA: BullishOct 14, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BearishOct 5, 20264 weeks ago
SMA: BullishSep 29, 20261 month ago
SMA: BullishSep 29, 20261 month ago
MACD: Buy SignalSep 29, 20261 month ago
MACD: Sell SignalSep 25, 20261 month ago
SMA: BearishSep 24, 20261 month ago
SMA: BearishSep 24, 20261 month ago
SMA: BullishSep 23, 20261 month ago
SMA: BullishSep 23, 20261 month ago
SMA: BearishSep 18, 20261 month ago
SMA: BullishSep 16, 20261 month ago
SMA: BullishSep 15, 20261 month ago
SMA: BearishSep 14, 20261 month ago
SMA: BullishSep 11, 20261 month ago
MACD: Buy SignalSep 11, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
MACD: Buy SignalAug 24, 20262 months ago
MACD: Sell SignalAug 20, 20262 months ago
SMA: BearishAug 18, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 14, 20262 months ago
SMA: BullishAug 11, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 6, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago

Financial health

Altman Z-Score

-149.51 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -3.3×
FY 2016: -0.7×FY 2017: -8.8×FY 2018: -146×FY 2019: -11.6×FY 2020: -6.0×FY 2021: -9.8×FY 2022: -22.4×FY 2023: -4.7×FY 2024: -5.3×FY 2025: -3.3×
FY 2016 5y median -5.3× FY 2025
P/S 0.0×
FY 2016: 1.9×FY 2017: 14.5×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -2.7×
FY 2016: -1.6×FY 2017: 5.1×FY 2018: -193×FY 2019: -30.4×FY 2020: -8.0×FY 2021: -15.4×FY 2022: -20.5×FY 2023: -8.3×FY 2024: -7.0×FY 2025: -2.7×
FY 2016 5y median -8.3× FY 2025
P/FCF -13.2×
FY 2016: -10.9×FY 2017: -149×FY 2018: -233×FY 2019: -56.4×FY 2020: -20.3×FY 2021: -24.5×FY 2022: -30.1×FY 2023: -24.6×FY 2024: -148×FY 2025: -13.2×
FY 2016 5y median -24.6× FY 2025
EV/EBITDA -4.2×
FY 2016: -0.8×FY 2017: -9.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -10.8×FY 2022: -26.8×FY 2023: -5.8×FY 2024: -6.1×FY 2025: -4.2×
FY 2016 5y median -6.1× FY 2025
EV/Sales 0.0×
FY 2016: 2.3×FY 2017: 15.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -7.6%
FY 2016: -9.2%FY 2017: -0.7%FY 2018: -0.4%FY 2019: -1.8%FY 2020: -4.9%FY 2021: -4.1%FY 2022: -3.3%FY 2023: -4.1%FY 2024: -0.7%FY 2025: -7.6%
FY 2016 5y median -4.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 60.9%FY 2017: 45.6%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -272.3%FY 2017: -162.5%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -282.7%FY 2017: -166.6%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 81.9%
FY 2016: 239.8%FY 2017: -58.7%FY 2018: 131.6%FY 2019: 260.9%FY 2020: 132.7%FY 2021: 157.4%FY 2022: 91.2%FY 2023: 176.1%FY 2024: 132.1%FY 2025: 81.9%
FY 2016 5y median 132.1% FY 2025
ROIC 138.3%
FY 2016: 371.7%FY 2017: -57.3%FY 2018: -10402.6%FY 2019: -3155.9%FY 2020: 385.7%FY 2021: 406.8%FY 2022: 189.3%FY 2023: 323.8%FY 2024: 318.6%FY 2025: 138.3%
FY 2016 5y median 318.6% FY 2025
ROA -322.4%
FY 2016: -1348.4%FY 2017: -43.9%FY 2018: -814.1%FY 2019: -949.6%FY 2020: -1150.2%FY 2021: -3642.7%FY 2022: -664.2%FY 2023: -3109.6%FY 2024: -1706.4%FY 2025: -322.4%
FY 2016 5y median -1706.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -3.6%FY 2017: -22.5%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 16.6%
FY 2016: 67.9%FY 2017: 53.7%FY 2018: 30.9%FY 2019: -659.8%FY 2020: 22.2%FY 2021: -232.2%FY 2022: 49.4%FY 2023: -79.0%FY 2024: 41.8%FY 2025: 16.6%
FY 2016 FY 2025
EPS (diluted) -35.1%
FY 2016: 87.4%FY 2017: 69.6%FY 2018: 98.5%FY 2019: -597.1%FY 2020: -63.9%FY 2021: -2.2%FY 2022: 47.7%FY 2023: -49.1%FY 2024: 46.4%FY 2025: -35.1%
FY 2016 FY 2025
Free Cash Flow -527.2%
FY 2016: -1477.6%FY 2017: 56.3%FY 2018: -903.9%FY 2019: -131.9%FY 2020: -157.3%FY 2021: -56.4%FY 2022: -6.0%FY 2023: 55.4%FY 2024: 89.8%FY 2025: -527.2%
FY 2016 FY 2025

Financial Health

Current Ratio 0.2×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.2×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.2×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.2×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -0.5×
FY 2016: -0.4×FY 2017: 0.2×FY 2018: -1.0×FY 2019: -1.1×FY 2020: -0.6×FY 2021: -0.8×FY 2022: -0.8×FY 2023: -0.8×FY 2024: -0.6×FY 2025: -0.5×
FY 2016 5y median -0.8× FY 2025
Net Debt / EBITDA -0.4×
FY 2016: -0.1×FY 2017: -0.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -0.5×FY 2022: -0.9×FY 2023: -0.5×FY 2024: -0.5×FY 2025: -0.4×
FY 2016 5y median -0.5× FY 2025
Interest Coverage -10.0×
FY 2016: -86.1×FY 2017: -39.8×FY 2018: -25.6×FY 2019: -7.2×FY 2020: -1.0×FY 2021: -13.4×FY 2022: -4.1×FY 2023: -7.1×FY 2024: -2.9×FY 2025: -10.0×
FY 2016 5y median -7.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31